52-OR: Effect of Oral Nonpeptide GLP-1 Receptor Agonist Orforglipron (LY3502970) in Participants with Obesity or Overweight—A Phase 2 StudySean Wharton,Thomas Blevins,Lisa Connery,JULIO ROSENSTOCK,Sohini Raha,Kieren J. Mather,AXEL HAUPT,Deborah A. Robins,EDWARD J. PRATT,CHRISTOF M. KAZDA,Маниге КонигDiabetes（2023）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
